• ATOMOXETINE CHEMBL641 FDA Approved

    Alternate Names:

    Atomoxetine
    Strattera
    178103695
    7118
    D02574
    TOMOXETINE [INN]
    214424
    PA134688071
    0002-3227-30
    CC1CCCCC1O[C@H](CCNC)C2CCCCC2
    2262800
    49516
    TOMOXETINE
    127342
    DAP000721
    DB00289
    54841
    TOMOXETINA [SPANISH]
    46506160
    TOMOXETINUM [LATIN]
    50133749
    BENZENEPROPANAMINE, N-METHYL-|A-(2-METHYLPHENOXY)-, (|AR)-
    (3R)-N-METHYL-3-(2-METHYLPHENOXY)-3-PHENYL-PROPAN-1-AMINE
    METHYL[(3R)-3-(2-METHYLPHENOXY)-3-PHENYLPROPYL]AMINE
    (R)-N-METHYL-GAMMA-(2-METHYLPHENOXY)BENZENEPROPANAMINE
    Q-200658
    N-METHYL-3-(3-(O-TOLYLOXY)PHENYL)PROPAN-1-AMINE
    A10068
    KB-63304
    BC208687
    AN-36091
    AJ-31797
    NE63594
    AKOS015961834
    BDBM50366567
    ZINC1842633
    VHGCDTVCOLNTBX-QGZVFWFLSA-N
    MOLPORT-002-052-062
    GTPL7118
    BEN636
    ASW034S0B8
    (R)-TOMOXETINE|||TOMOXETINE
    SCHEMBL34268
    PUBCHEM23267
    CID54841
    (R)-TOMOXETINE
    (R)-ATOMOXETINE
    TOMOXETIN
    STRATTERAREG
    (R)-N-METHYL-3-(2-METHYL PHENOXY)BENZENEPROPANAMINE
    82248-59-7
    BENZENEPROPANAMINE, N-METHYL-GAMMA-(2-METHYLPHENOXY)-, (GAMMAR)-
    BRD-K20141153-003-03-8
    (R)-N-METHYL-3-(2-METHYLPHENOXY)BENZENEPROPANAMINE
    D07473
    LS-187331
    (3R)-N-METHYL-3-(2-METHYLPHENOXY)-3-PHENYLPROPAN-1-AMINE
    NCGC00025345-01
    AC-5316
    PDSP2_000502
    PDSP1_000504
    HSDB 7352
    AC1Q57N5
    AC1L1HTI
    TOCRIS-2011
    CHEBI:127342
    ATOMOXETINE (INN)
    UNII-ASW034S0B8
    83015-26-3
    (-)-TOMOXETINE
    TOMOXETINUM
    TOMOXETINA

    Drug Info:

    FDA Approval approved
    Drug Class Small Molecule
    Drug Indications for treatment of ADHD
    Drug Type drug/small molecule
    ATC n06ba(centrally acting sympathomimetics)
    MeSH c041930(atomoxetine)
    Year of Approval 2002
    Drug Class central nervous system agents, non-stimulant
    (3 More Sources)

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False
    Direct Interaction? False

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Trial Name atomoxetine hydrochloride,Strattera
    Novel drug target Established target
    Specific Action of the Ligand Inhibition

    Publications:

  • Interaction Types:
    inhibitor

    Interaction Info:
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False
    Direct Interaction? False

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:

    Publications:

    • Version: 12-July-2012

    Alternate Names:
    ATOMOXETINE Primary Drug Name
    50133749 bindingDb
    TOMOXETINUM [LATIN] Drug Generic Name

    Drug Info:
    MeSH c041930(atomoxetine)
    ATC n06ba(centrally acting sympathomimetics)
    Drug Type drug/small molecule

    Publications:

    • Version: 01-August-2011

    Alternate Names:
    ATOMOXETINE Primary Drug Name

    Drug Info:
    Drug Class central nervous system agents, non-stimulant
    Year of Approval 2002

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications for treatment of ADHD
    Drug Class Small Molecule
    FDA Approval approved

    Publications:

    • Version: 09-Feb-2016

    Alternate Names:
    ATOMOXETINE pubchem_primary_name
    54841 PubChem CID
    TOMOXETINE Drug Synonym

    Drug Info:

    Publications:

    • Version: 4.3.02 (25-August-2011)

    Alternate Names:
    DB00289 Drug Synonym
    82248-59-7 CAS Number
    NCGC00025345-01 Drug Synonym

    Drug Info:

    Publications:

    • Version: 27-September-2017

    Alternate Names:
    ATOMOXETINE GuideToPharmacology Ligand Name
    178103695 PubChem Drug SID

    Drug Info:

    Publications:

    • Version: 15-September-2017

    Alternate Names:

    Drug Info:

    Publications: